Fibrosarcomatous dermatofibrosarcoma protuberans in a seven-year-old boy

Abstract

3. European Medicines Agency. Dupixent EPAR – Product Information; 2017. Available at: www.ema.europa.eu/en/documents/productinformation/dupixent-epar-product-information_en.pdf.(accessed 19 Mar 2020). 4. Mollanazar NK, Smith PK, Yosipovitch G. Mediators of chronic pruritus in atopic dermatitis: getting the itch out? Clin Rev Allergy Immunol 2016; 51: 263-92. 5. Beck LA, Thaci D, Hamilton JD, et al. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis. N Engl J Med 2014; 371: 130-9. 6. Ribero S, Giura MT, Viola R, et al. Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in adult cohort: a reallife Italian tertiary centre experience. J Eur Acad Dermatology Venereol 2020; 34: e380-3. 7. Kovács B, Rose E, Kuznik N, et al. Dupilumab for treatmentrefractory prurigo nodularis. J Dtsch Dermatol Ges 2020; 18: 618-64.